Drug Research
Bluebird Hits $3m Mark With Gene Therapy After FDA Approval
Within one firm, the title of most costly treatment in the world has changed hands within a month.
Bluebird Bio has received an FDA fast clearance for Skysona, also known as eli-cel, for the uncommon neurological condition cerebral adrenoleukodystrophy (CALD),...
Drug Research
First Next-Gen Parkinsons Med To Be Made By Neuron23, QIAGEN
QIAGEN and Neuron23TM Inc., an early-stage biotechnology company focused on creating precision medications for genetically defined neurological and immunological illnesses, have announced a partnership to create a companion diagnostic for Neuron23's LRRK2 inhibitor for Parkinson's disease.
According to the terms...
Drug Research
Australia Permits New Treatment For Rare Bile Duct Cancer
Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The Therapeutic Goods Administration (TGA) has granted PEMAZYRE (pemigatinib) provisional approval for the treatment of adult patients with metastatic...
Drug Research
Beyfortus From Sanofi And Astrazeneca Is Supported By RSV
Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to treat lower respiratory tract sickness caused by the respiratory syncytial virus (RSV) in neonates and young children.
If authorised, Beyfortus,...
Drug Research
canSERV, EU Cluster Effort, Offers Cancer Study In Europe
Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will give academia and business exposure to cross-cutting services and assistance from fundamental science up to clinical application over the...
Drug Research
WHO Strongly Advises Against The Use of 2 COVID Therapies
The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on the grounds that Omicron and the variant's most recent offspring have probably made them ineffective.
The two treatments were among the first drugs created in...
News
Day 1- CONNECT IN PHARMA, Geneva, Switzerland
Happiness can never be stalled, and that was pretty evident on Day 1 of Connect in Pharma.
To advance innovation in a cooperative setting, Connect in Pharma has brought together specialists in the pharmaceutical and biotech industries under one...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read